Get started
ATAI LIFE SCIENCES BV EO1ATAI LIFE SCIENCES BV EO1ATAI LIFE SCIENCES BV EO1

ATAI LIFE SCIENCES BV EO1

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

9VC chart


Full chart

9VC upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪246.47 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.7225 EUR
Net income (FY)
‪−144.19 M‬ EUR
Revenue (FY)
‪297.52 K‬ EUR
Shares float
‪136.18 M‬
Beta (1Y)
1.41

Employees


Employees (FY)
54
Change (1Y)
−29 −34.94%
Revenue / Employee (1Y)
‪5.51 K‬ EUR
Net income / Employee (1Y)
‪−2.67 M‬ EUR

About ATAI Life Sciences N.V.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Srinivas G. Rao
Website
atai.life
Headquarters
Berlin
Founded
2018
ISIN
NL0015000DX5
FIGI
BBG011HTB305
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

9VC news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 9VC.

Frequently Asked Questions


The current price of 9VC is 1.2670 EUR — it has decreased by −0.49% in the past 24 hours. Watch ATAI LIFE SCIENCES BV EO1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ATAI LIFE SCIENCES BV EO1 stocks are traded under the ticker 9VC.
9VC stock has risen by 2.39% compared to the previous week, the month change is a −1.57% fall, over the last year ATAI LIFE SCIENCES BV EO1 has showed a −25.91% decrease.
We've gathered analysts' opinions on ATAI LIFE SCIENCES BV EO1 future price: according to them, 9VC price has a max estimate of 9.65 EUR and a min estimate of 4.39 EUR. Watch 9VC chart and read a more detailed ATAI LIFE SCIENCES BV EO1 stock forecast: see what analysts think of ATAI LIFE SCIENCES BV EO1 and suggest that you do with its stocks.
9VC reached its all-time high on Jul 5, 2021 with the price of 18.5000 EUR, and its all-time low was 0.9435 EUR and was reached on Dec 1, 2023. View more price dynamics on 9VC chart.
See other stocks reaching their highest and lowest prices.
9VC stock is 3.63% volatile and has beta coefficient of 1.41. Track ATAI LIFE SCIENCES BV EO1 stock price on the chart and check out the list of the most volatile stocks — is ATAI LIFE SCIENCES BV EO1 there?
Today ATAI LIFE SCIENCES BV EO1 has the market capitalization of ‪258.45 M‬, it has increased by 3.80% over the last week.
Yes, you can track ATAI LIFE SCIENCES BV EO1 financials in yearly and quarterly reports right on TradingView.
ATAI LIFE SCIENCES BV EO1 is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
9VC earnings for the last quarter are −0.23 EUR per share, whereas the estimation was −0.15 EUR resulting in a −51.35% surprise. The estimated earnings for the next quarter are −0.16 EUR per share. See more details about ATAI LIFE SCIENCES BV EO1 earnings.
ATAI LIFE SCIENCES BV EO1 revenue for the last quarter amounts to ‪−4.83 K‬ EUR, despite the estimated figure of ‪289.79 K‬ EUR. In the next quarter, revenue is expected to reach 0.00 EUR.
9VC net income for the last quarter is ‪−23.61 M‬ EUR, while the quarter before that showed ‪−53.51 M‬ EUR of net income which accounts for 55.88% change. Track more ATAI LIFE SCIENCES BV EO1 financial stats to get the full picture.
No, 9VC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 23, 2025, the company has 54 employees. See our rating of the largest employees — is ATAI LIFE SCIENCES BV EO1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ATAI LIFE SCIENCES BV EO1 EBITDA is ‪−94.78 M‬ EUR, and current EBITDA margin is ‪−33.19 K‬%. See more stats in ATAI LIFE SCIENCES BV EO1 financial statements.
Like other stocks, 9VC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ATAI LIFE SCIENCES BV EO1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ATAI LIFE SCIENCES BV EO1 technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ATAI LIFE SCIENCES BV EO1 stock shows the sell signal. See more of ATAI LIFE SCIENCES BV EO1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.